AGM/EGMApr 17, 2026, 04:32 PM
Alzamend Neuro Stockholders Approve All 7 Proposals at Annual Meeting
AI Summary
Alzamend Neuro, Inc. held its annual meeting on April 17, 2026, where stockholders approved all seven proposals presented. This included the election of seven director nominees to the board. Additionally, Haskell & White LLP was ratified as the company's independent registered public accounting firm for the fiscal year ending April 30, 2026.
Key Highlights
- Alzamend Neuro held its Annual Meeting on April 17, 2026.
- Stockholders approved all seven proposals presented at the meeting.
- Seven director nominees were elected to hold office.
- Haskell & White LLP was ratified as the independent auditor for FY2026.
- 3,804,741 shares were outstanding and entitled to vote on the record date.
Price Impact
More from ALZN